Welcome to LookChem.com Sign In | Join Free Post buying lead Chemical Tools
Home > Hot Product_List > Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1)

Basic information

  • Name:
  • Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1)

  • Superlist Name:
  • Nimustine hydrochloride
  • CAS No.:
  • 55661-38-6

  • Molecular Structure:
  • Formula:
  • C9H13ClN6O2.ClH
  • Molecular Weight:
  • 309.15
  • Deleted CAS:
  • 52208-23-8
  • Synonyms:
  • Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,monohydrochloride (9CI);1-(4-Amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosoureahydrochloride;ACNU;NSC-D 245382;Nidran;Nimustine hydrochloride;3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride;N'-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea hydrochloride;CS 439 HCl;CS-439;Nimustine HCl;
  • Boiling Point:
  • 471.6 °C at 760 mmHg
  • Flash Point:
  • 239 °C
  • Appearance:
  • white to light yellow solid.
  • Hazard Symbols:
  • ToxicT
  • Risk Codes:
  • 25
  • Safety Description:
  • 36/37/39-45 Details
  • Transport Information:
  • UN 2811

Famous Chemical Enterprises

  • Livzon
  • Total
  • Shell
  • Dupont
  • Exxonmobil
  • Akzonobel
  • Basf
  • Bayer
  • BP

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Specification

The Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1) with CAS registry number of 55661-38-6 is also known as N'-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea hydrochloride. The IUPAC name is 3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride. It belongs to product categories of Antitumors for Research and Experimental Use; Biochemistry. This chemical is a white to light yellow crystalline powder. In addition, the formula is C9H13ClN6O2.ClH and the molecular weight is 309.15.

Physical properties about Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1) are: (1)ACD/LogP: 0.19; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.09; (4)ACD/LogD (pH 7.4): 0.18; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 15.88; (8)ACD/KOC (pH 7.4): 29.73; (9)#H bond acceptors: 8; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 82Å2; (13)Flash Point: 239 °C; (14)Enthalpy of Vaporization: 74.84 kJ/mol; (15)Boiling Point: 471.6 °C at 760 mmHg; (16)Vapour Pressure: 2.72E-09 mmHg at 25 °C.

Preparation of Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1): add urea(1.5mol), 2-aminoethanol 92g (1.5mol) and DMF 750ml in the reaction flask. Stirred, heated and refluxed for 8 ~ 9h. Evaporate recovery DMF, then add 2-amino alcohol 66g (1.1mol) to residues under stirring for 2h. Thionyl chloride 195ml(319.4g, 2.68mol) was added dropwise under stirring at 0 °C, placed overnight. Heated to 100-120 °C and stirred for 2~3h, solids are precipitated. agglomerated material will be carefully broken up, filtered, washed, drained. Recrystallize with methanol to get 1,3-bis (2-chloroethyl) urea 86g. The yield is about 32%.

Uses of Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1): it is clinically used to relieve brain tumors, gastrointestinal tumors (stomach cancer, liver cancer, colorectal cancer), lung cancer, malignant lymphoma and chronic leukemia. Compared with similar alkylating agent products, this chemical has less toxicity, well water solubility for intravenous administration. This chemical can be used for treatment of intracranial tumors.

When you are using this chemical, please be cautious about it. As a chemical, it is toxic if swallowed. During using it, wear suitable protective clothing, gloves and eye/face protection. In case of accident or if you feel unwell seek medical advice immediately.

You can still convert the following datas into molecular structure:
1. SMILES: Cl.ClCCN(N=O)C(=O)NCc1cnc(nc1N)C
2. InChI: InChI=1/C9H13ClN6O2.ClH/c1-6-12-4-7(8(11)14-6)5-13-9(17)16(15-18)3-2-10;/h4H,2-3,5H2,1H3,(H,13,17)(H2,11,12,14);1H
3. InChIKey: KPMKNHGAPDCYLP-UHFFFAOYAA
4. Std. InChI: InChI=1S/C9H13ClN6O2.ClH/c1-6-12-4-7(8(11)14-6)5-13-9(17)16(15-18)3-2-10;/h4H,2-3,5H2,1H3,(H,13,17)(H2,11,12,14);1H
5. Std. InChIKey: KPMKNHGAPDCYLP-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous 5mg/kg (5mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
"Current Chemotherapy, Proceedings of the 10th International Congress of Chemotherapy, Zurich 1977," Siegenthaler, W., and R. Luethy, eds., 2 vols., Washington, DC, American Soc. for Microbiology, 1978Vol. 2, Pg. 1233, 1978.
dog LDLo oral 5mg/kg (5mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
"Current Chemotherapy, Proceedings of the 10th International Congress of Chemotherapy, Zurich 1977," Siegenthaler, W., and R. Luethy, eds., 2 vols., Washington, DC, American Soc. for Microbiology, 1978Vol. 2, Pg. 1233, 1978.
mouse LD50 intraperitoneal 49300ug/kg (49.3mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 884, 1979.
mouse LD50 intravenous 59mg/kg (59mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
"Current Chemotherapy, Proceedings of the 10th International Congress of Chemotherapy, Zurich 1977," Siegenthaler, W., and R. Luethy, eds., 2 vols., Washington, DC, American Soc. for Microbiology, 1978Vol. 2, Pg. 1233, 1978.
mouse LD50 oral 83mg/kg (83mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
"Current Chemotherapy, Proceedings of the 10th International Congress of Chemotherapy, Zurich 1977," Siegenthaler, W., and R. Luethy, eds., 2 vols., Washington, DC, American Soc. for Microbiology, 1978Vol. 2, Pg. 1233, 1978.
mouse LD50 subcutaneous 72800ug/kg (72.8mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 884, 1979.
rat LD50 intraperitoneal 52700ug/kg (52.7mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 884, 1979.
rat LD50 intravenous 15mg/kg (15mg/kg)   Medicamentos de Actualidad. Vol. 16, Pg. 424, 1980.
rat LD50 oral 113mg/kg (113mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
"Current Chemotherapy, Proceedings of the 10th International Congress of Chemotherapy, Zurich 1977," Siegenthaler, W., and R. Luethy, eds., 2 vols., Washington, DC, American Soc. for Microbiology, 1978Vol. 2, Pg. 1233, 1978.
rat LD50 subcutaneous 60800ug/kg (60.8mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 884, 1979.

Please post your buying leads
so that our qualified suppliers will soon contact you!

©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

[Hangzhou]86-571-85317600,85317603,85317620